Cargando…
Small-Molecule Ligands as Potential GDNF Family Receptor Agonists
[Image: see text] To find out potential GDNF family receptor α1 (GFRα1) agonists, small molecules were built up by molecular fragments according to the structure-based drug design approach. Molecular docking was used to identify their binding modes to the biological target GFRα1 in GDNF-binding pock...
Autores principales: | Ivanova, Larisa, Tammiku-Taul, Jaana, Sidorova, Yulia, Saarma, Mart, Karelson, Mati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045390/ https://www.ncbi.nlm.nih.gov/pubmed/30023796 http://dx.doi.org/10.1021/acsomega.7b01932 |
Ejemplares similares
-
Molecular Dynamics Simulations of the Interactions
between Glial Cell Line-Derived Neurotrophic Factor Family Receptor
GFRα1 and Small-Molecule Ligands
por: Ivanova, Larisa, et al.
Publicado: (2018) -
1,3-Thiazolbenzamide Derivatives as Chikungunya Virus
nsP2 Protease Inhibitors
por: Ivanova, Larisa, et al.
Publicado: (2021) -
A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat
por: Sidorova, Yulia A., et al.
Publicado: (2017) -
Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats
por: Renko, Juho-Matti, et al.
Publicado: (2021) -
GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson’s Disease
por: Renko, Juho-Matti, et al.
Publicado: (2020)